Work

The bortezomib/proteasome inhibitor PS-341 and triterpenoid CDDO-Im induce synergistic anti–multiple myeloma (MM) activity and overcome bortezomib resistance

Year: 2003

Type: article

Source: Blood

DOI: 10.1182/blood-2003-08-2873

Authors: Dharminder Chauhan, Guilan Li, Klaus Podar, Teru Hideshima, Reshma Shringarpure, Laurence Catley, Constantine Mitsiades, Nikhil Munshi, Yu Tzu Tai, Nanjoo Suh, Gordon W. Gribble, Tadashi Honda, Robert Schlossman, Paul Richardson, Michael B. Sporn, Kenneth C. Anderson

Institutions: Dartmouth College, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Dartmouth Health

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, U.S. Public Health Service, National Cancer Institute

Awards: G1431502814, G1686585682, Host-tumor cell interaction in myeloma: therapeutic applications, SPORE in Multiple Myeloma, New Triterpenoids for Chemoprevention and Therapy of Cancer, G634946495, G7947295115

OpenAlex ID: W2168268910

FWCI: 5.481

Cites: 54

Cited by: 131

Related to: 10